79. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Freitag, 5. April 2013 (Saal 21) 08:30-10:00

Freie Vorträge

Signaltransduktion bei Herzinsuffizienz

Vorsitz: D. Dobrev (Essen), B. Hornig (Basel, CH)

(V999) Phoshodiesterase 2 maintains resting heart rate in the healthy heart but becomes markedly upregulated in diseased hearts and desensitizes against β-AR mediated inotropic effects

C. Vettel, H. Mehel, J. Emons, K. Wittköpper, M. Dewenter, S. Lämmle, D. Seppelt, M. Riedel, S. Napiany, S. Lutz, S. T. Sossalla, P. Lechene, L. S. Maier, V. Nikolaev, W.-H. Zimmermann, T. Eschenhagen, G. Vandecasteele, R. Fischmeister, A. El-Armouche (Göttingen, Hamburg; Châtenay-Malabry, FR)
(V1000) Gene Therapy with Glucose-related Protein 78 (GRP78) Targeting Doxorubicin Cardiomyopathy

H. Tscheschner, J. Reinkober, P. Most, H. A. Katus, M. Müller, O. J. Müller, P. Raake (Heidelberg)
(V1001) Myoscape (Muscle enriched Calcium-Channel associated protein), controls  L-type Calcium Channel function and regulates cardiac contractility in vivo

M. Eden, B. Meder, R. Will, M. Völkers, C. Heymes, G. Poomvanicha, K. Domes, H. A. Katus, F. Hofmann, W. Rottbauer, P. Most, N. Frey (Kiel, Heidelberg, München, Ulm; Paris, FR)
(V1002) PKA phosphorylates the pentameric form of phospholamban, a crucial regulator of myocyte calcium cycling

T. Wittmann, M. Lohse, J. Schmitt (Würzburg, Düsseldorf)
(V1003) Nucleoside Diphosphate Kinase C is an Essential Regulator of G-Protein Content and cAMP Production in Cardiomyocytes

I. Abu-Taha, N. Wolf, C. Würtz, S. Lutz, A. El-Armouche, V. Nikolaev, H.-J. Hippe, D. Dobrev, T. Wieland (Essen, Heidelberg, Göttingen, Kiel, Mannheim)
(V1004) Global beta-adrenoceptor blockade versus genetic deletion of phosphatase inhibitor-1 in CaMKIIδc-induced severe heart failure

M. Dewenter, S. Neef, C. Brammen, J. H. Brown, L. S. Maier, A. El-Armouche (Göttingen; La Jolla, US)